Ending the Cycle: A new study could break one woman’s lifetime of addiction
The odds appeared to be stacked against Leah* from the beginning. Raised by addicted parents, she started drinking at age 13. By 16, she was using Ecstasy at rave parties several times a week. She dropped out of school. Then…
UTHealth a site for first-ever large NIDA trial for methamphetamine use disorder
With the rates of methamphetamine use reaching an all-time high in Texas, McGovern Medical School researchers have launched a clinical trial designed to treat methamphetamine use disorder. The Center for Neurobehavioral Research on Addiction (CNRA) in the Department of Psychiatry…
Researchers recruiting children with autism
Researchers at McGovern Medical School are conducting a 14-week, placebo-controlled research study to assess the safety and effectiveness of an investigational medication (CM-AT) to treat the symptoms of autism in children ages 3 to 8. CM-AT is an enzyme formulation children…